Innovative R&D

Innovative R&D

Innovative R&D

05th

Mar,2026

Keratin has garnered widespread attention due to its outstanding mechanical properties, thermal stability, and bioactive functions such as promoting hemostasis and wound healing. Traditionally, keratin has been extracted from natural sources like human hair, wool, and feathers and processed into biomaterials—including thin films, hydrogels, and nanoparticles—primarily for biomedical applications. However, conventional extraction methods often yield heterogeneous keratin mixtures containing residual impurities and structural damage caused by harsh purification conditions, complicating efforts to elucidate how specific keratins and their hierarchical assemblies contribute to the desired material properties. Recombinant keratin technology addresses these challenges by enabling the synthesis of highly pure, batch‑consistent single‑type keratins. These advances have facilitated in‑depth investigations into how keratin’s behavior at different assembly levels—from molecular components and heterodimers to intermediate filaments and their networks—shapes material performance. Moreover, this technology permits precise genetic modifications, holding promise for developing tailored keratin variants with customized properties for specific applications. Despite these advantages, translating recombinant keratin into practical applications still requires overcoming key manufacturing hurdles, such as optimizing large‑scale production and enhancing purification efficiency. This review summarizes the current state of research on recombinant keratin, highlighting recent technological advances and exploring its applications in contemporary biomaterials. Although its use remains relatively limited compared to traditionally extracted keratin, recombinant keratin holds significant potential for advanced materials design and other non‑medical fields.

Read More

< 1 > proceed page